Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market
06 févr. 2023 09h02 HE
|
Sharps Technology Inc
NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented,...
Sharps Technology Announces Pricing of $3.8 Million Private Placement Priced at the Market
01 févr. 2023 09h20 HE
|
Sharps Technology Inc
NEW YORK, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”, "Sharps") (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented,...
Sharps Technology Ships First Containers of Safety Syringes to Nephron Pharmaceuticals for Commercialization
31 janv. 2023 08h00 HE
|
Sharps Technology Inc
First product shipped from Sharps' facility in Hungary and first to support the Nephron Pharmaceuticals distribution and sales collaboration Sharps anticipates 1.3 million units to be...
Sharps Technology Inc. to Introduce New Specialized Prefillable Syringe Systems in 2023
10 janv. 2023 08h00 HE
|
Sharps Technology Inc
High-Value specialized prefillable syringe systems to accelerate revenue growth in 2023 and beyond Company to launch next generation specialty polymer-based syringe products for the healthcare market...
Sharps Technology Begins Manufacturing at its Hungary Facility for the Company's Innovative Syringe Products
20 déc. 2022 08h00 HE
|
Sharps Technology Inc
Company now transitions from a pre-revenue research & development start-up to a revenue generating manufacturing company Shipments to commence by the end of the year to support the recently...
Sharps Technology and Nephron Pharmaceuticals Sign Distribution Agreement for its Innovative Syringe Products
13 déc. 2022 08h00 HE
|
Sharps Technology Inc
Company anticipates products to be available in the first quarter of 2023 with initial revenue from this agreement expected in the first half of the year Strengthens the collaboration between Sharps...
Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce Manufacturing and Research Partnership
10 nov. 2022 16h05 HE
|
Sharps Technology Inc
WEST COLUMBIA, S.C. and NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative...
Sharps Technology Completes Acquisition of Safegard Medical Syringe Manufacturing Facility
14 juil. 2022 16h05 HE
|
Sharps Technology Inc
NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class, single use...
Sharps Technology Announces Letter to Shareholders
08 juin 2022 16h05 HE
|
Sharps Technology Inc
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), is an innovative medical device company offering patented, best-in-class, single use...
Sharps Technology, Inc. Announces Closing of $16 Million Initial Public Offering
19 avr. 2022 09h50 HE
|
Sharps Technology Inc
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class, single use...